Vitamin C enhances chemosensitization of esophageal cancer cells in vitro.
Chemotherapy is increasingly utilised in multimodal protocols to try and improve outcomes. Cisplatin and 5-fluorouracil (5-Fu) are the mainstay of chemotherapeutic regimens, and an understanding of sensitivity and resistance of esophageal cancer to these agents is of considerable clinical importance. Antioxidants may modulate the response to chemotherapy, and in this study we examined the effect of vitamin C on 5-Fu and cisplatin cytotoxicity and related pathways in the esophageal cancer cell lines OE33 and SKGT-4. The antiproliferative effect of antitumor agents was measured by the MTT assay, and the transcription factors NF-kappaB and AP-1 pathways were assessed by electrophoretic mobility gel shift assay. 5-Fu and cisplatin demonstrated marked morphological changes and decreased cell proliferation. A combination of vitamin C with 5-Fu or cisplatin exerted a significantly enhanced cytotoxic effect compared to both drugs individually. Treatment of esophageal cancer cells with 5-Fu and cisplatin induced NF-kappaB and AP-1 activation. Pretreatment with vitamin C inhibited 5-Fu or cisplatin induced NF-kappaB nuclear translocation and DNA binding activity, but vitamin C had no effect on IkappaB-alpha protein levels. Vitamin C also inhibited 5-Fu- and cisplatin-induced AP-1 activation. Our data demonstrate that vitamin C enhances the antitumor activity of 5-Fu and cisplatin, in part by inhibiting translocation of NF-kappaB and AP-1, and sensitizes cancer cells to drug-induced cell death. The data suggest that vitamin C supplementation may improve the efficacy of chemotherapy for esophageal cancer.
Abdel-Latif
M M M
MM
Department of Surgery, Trinity Centre for Health Sciences, St James's Hospital, Dublin, Ireland. abdellmm@tcd.ie
Raouf
A A
AA
Sabra
K
K
Kelleher
D
D
Reynolds
J V
JV
D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D001205:Ascorbic Acid / Q000494:pharmacology*; D049109:Cell Proliferation; D002945:Cisplatin / Q000494:pharmacology*; D004347:Drug Interactions; D004938:Esophageal Neoplasms / Q000473:pathology*; D005472:Fluorouracil / Q000494:pharmacology*; D006801:Humans; D016328:NF-kappa B / Q000096:biosynthesis / Q000378:metabolism; D018808:Transcription Factor AP-1 / Q000096:biosynthesis / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D000975:Antioxidants; D016328:NF-kappa B; D018808:Transcription Factor AP-1; D001205:Ascorbic Acid; D002945:Cisplatin; D005472:Fluorouracil